Bio-Techne TECH Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $162.19M+6.8% | $151.79M-15.9% | $180.57M+4.6% | $172.57M-13.3% | ||
| $206.88M-14.3% | $241.39M+10.5% | $218.47M+12.3% | $194.55M+33.8% | ||
| $753.94M+3.8% | $726.15M+11.5% | $651.34M+134% | $278.11M— | ||
| $37.46M+11.3% | $33.66M+24.4% | $27.07M+18.4% | $22.86M+35.1% | ||
| $12.33M+26.2% | $9.77M— | $0— | —— | ||
| $608.3M-1.5% | $617.42M-0.7% | $621.48M+2.6% | $605.56M+18.6% | ||
| $245.72M-2.2% | $251.15M+11.0% | $226.2M+1.3% | $223.24M+7.4% | ||
| $73.4M-19.6% | $91.29M-7.2% | $98.33M+50.0% | $65.56M-11.2% | ||
| $980.94M+0.9% | $972.66M+11.4% | $872.74M+6.2% | $822.1M-2.5% | ||
| $365.6M-27.9% | $507.08M-5.2% | $534.65M+0.6% | $531.52M-13.7% | ||
| $283.92M+7.4% | $264.27M-7.4% | $285.3M+509% | $46.83M+305% | ||
| $2.56B-5.4% | $2.7B+2.5% | $2.64B+15.0% | $2.29B+1.4% | ||
| $25.31M-33.3% | $37.97M+47.9% | $25.68M-24.2% | $33.87M+15.2% | ||
| $65.79M+32.1% | $49.82M+35.6% | $36.75M-40.7% | $61.95M+20.8% | ||
| $32.57M+16.6% | $27.93M+21.1% | $23.07M-1.4% | $23.41M+23.2% | ||
| $14.1M+9.1% | $12.92M+15.4% | $11.2M-6.1% | $11.93M+2.8% | ||
| $20.68M-27.1% | $28.37M-61.0% | $72.74M+330% | $16.93M+81.6% | ||
| $175.85M+10.3% | $159.38M+24.0% | $128.51M-27.0% | $176.02M+15.6% | ||
| $346M+8.5% | $319M-8.9% | $350M+43.8% | $243.41M-26.0% | ||
| $83.96M-4.2% | $87.62M-6.6% | $93.77M+61.3% | $58.13M-14.0% | ||
| $98.06M-2.5% | $100.54M-4.2% | $104.97M+49.8% | $70.06M— | ||
| $27.08M+106% | $13.16M+20.5% | $10.92M-10.8% | $12.24M-50.0% | ||
| $1.55M-2.0% | $1.58M+0.4% | $1.58M+0.6% | $1.57M+302% | ||
| $911.09M+11.1% | $820.34M+13.7% | $721.54M+10.6% | $652.47M+22.1% | ||
| $1.07B-19.6% | $1.33B+1.2% | $1.31B+16.6% | $1.12B+3.5% | ||
| -$59.88M+23.5% | -$78.32M-18.5% | -$66.06M+12.1% | -$75.2M-31.3% | ||
| $1.92B-7.3% | $2.07B+5.2% | $1.97B+15.6% | $1.7B+8.9% | ||
| $2.56B-5.4% | $2.7B+2.5% | $2.64B+15.0% | $2.29B+1.4% | ||
| $37.46M+11.3% | $33.66M+24.4% | $27.07M+18.4% | $22.86M+35.1% | ||
| $283.92M+7.4% | $264.27M-7.4% | $285.3M+509% | $46.83M+305% | ||
| $73.4M-19.6% | $91.29M-7.2% | $98.33M+50.0% | $65.56M-11.2% | ||
| $10.31M— | —— | —— | —— | ||
| $365.6M-27.9% | $507.08M-5.2% | $534.65M+0.6% | $531.52M-13.7% | ||
| $73.4M-19.6% | $91.29M-7.2% | $98.33M+50.0% | $65.56M-11.2% | ||
| $283.92M+7.4% | $264.27M-7.4% | $285.3M+509% | $46.83M+305% | ||
| $73.4M-19.6% | $91.29M-7.2% | $98.33M+50.0% | $65.56M-11.2% | ||
| $283.92M+7.4% | $264.27M-7.4% | $285.3M+509% | $46.83M+305% | ||
| $65.79M+32.1% | $49.82M+35.6% | $36.75M-40.7% | $61.95M+20.8% | ||
| $25.66M+3.1% | $24.89M+67.2% | $14.88M-16.8% | $17.89M+17.0% | ||
| $10.77M+191% | $3.71M-69.2% | $12.02M-9.2% | $13.24M+148% | ||
| $25.66M+3.1% | $24.89M+67.2% | $14.88M-16.8% | $17.89M+17.0% | ||
| $65.79M+32.1% | $49.82M+35.6% | $36.75M-40.7% | $61.95M+20.8% | ||
| $1.65M-23.5% | $2.15M+52.2% | $1.41M+13.7% | $1.24M-68.1% | ||
| $346M+8.5% | $319M-8.9% | $350M+43.8% | $243.41M-26.0% | ||
| $444.06M+5.8% | $419.54M-7.8% | $454.97M+39.6% | $325.97M-22.5% | ||
| $911.09M+11.1% | $820.34M+13.7% | $721.54M+10.6% | $652.47M+22.1% | ||
| $1.55M-2.0% | $1.58M+0.4% | $1.58M+0.6% | $1.57M+302% | ||
| $0— | $0— | $0— | $0— | ||
| $6.17M-89.0% | $55.86M-37.2% | $88.98M-10.1% | $98.99M+6.3% | ||
| $346M+8.5% | $319M-8.9% | $350M+43.8% | $243.41M-26.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bio-Techne's total assets?
- Bio-Techne (TECH) holds $2.6B in total assets, down 3.5% year over year.
- How much debt does Bio-Techne have?
- Bio-Techne carries $290.3M in total debt against $2.1B of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Bio-Techne have?
- Bio-Techne holds $209.8M in cash and equivalents.
- Can Bio-Techne cover its short-term obligations?
- Its current ratio is 4.49 — current assets exceed current liabilities.
- Where does Bio-Techne's balance sheet data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
